-
公开(公告)号:WO2005028457A1
公开(公告)日:2005-03-31
申请号:PCT/FI2004/000559
申请日:2004-09-23
申请人: FERMION OY , GRUMANN, Arne , HUHTA, Soini , RUMMAKKO, Petteri
发明人: GRUMANN, Arne , HUHTA, Soini , RUMMAKKO, Petteri
IPC分类号: C07D281/16
CPC分类号: C07D417/12 , C07C217/08 , C07C217/28 , C07D281/16 , C07D309/12
摘要: The present invention discloses a process for the preparation of quetiapine, which comprises the reaction of dibenzo[b,f][1,4]thiazepin-11-ylamine with a compound of the general formula (II) as well as novel intermediates in the process.
摘要翻译: 本发明公开了一种制备喹硫平的方法,其包括二苯并[b,f] [1,4]硫杂-11-基胺与通式(II)的化合物的反应以及新的中间体 处理。
-
2.
公开(公告)号:WO2007048870A1
公开(公告)日:2007-05-03
申请号:PCT/FI2006/000344
申请日:2006-10-26
申请人: FERMION OY , GRUMANN, Arne , HUHTA, Soini , RUMMAKKO, Petteri , LUSIS, Viesturs
IPC分类号: C07D281/16 , A61K31/554
CPC分类号: C07D281/16
摘要: ABSTRACT The present invention relates to a process for preparing and purifying crystalline quetiapine hemifumarate, which comprises preparing crystalline quetiapine hemifumarate via a crystalline salt, which is not a salt of fumaric acid.
摘要翻译: 摘要本发明涉及一种制备和纯化结晶喹硫平半富马酸盐的方法,该方法包括通过不是富马酸盐的结晶盐制备结晶喹硫平半富马酸盐。
-
公开(公告)号:WO2007036599A1
公开(公告)日:2007-04-05
申请号:PCT/FI2006/000318
申请日:2006-09-28
申请人: FERMION OY , RUMMAKKO, Petteri , GRUMANN, Arne , HUHTA, Soini , KOIRANEN, Tuomas
IPC分类号: C07D281/16 , A61K31/554 , A61P25/18
CPC分类号: C07D281/16
摘要: The present invention relates to a process for preparing crystalline quetiapine hemifumarate, which comprises crystallizing or re-crystallizing quetiapine hemifumarate from a mixture of water and a water soluble alcohol.
摘要翻译: 本发明涉及一种制备结晶喹硫平半富马酸盐的方法,其包括从水和水溶性醇的混合物中结晶或重结晶喹硫平半富马酸盐。
-
公开(公告)号:WO2006134212A3
公开(公告)日:2007-02-22
申请号:PCT/FI2006000201
申请日:2006-06-14
申请人: FERMION OY , GRUMANN ARNE , HUHTA SOINI , LUUKKONEN EILA , KOIRANEN TUOMAS
发明人: GRUMANN ARNE , HUHTA SOINI , LUUKKONEN EILA , KOIRANEN TUOMAS
IPC分类号: C07C303/40 , C07C311/37
CPC分类号: C07C303/40 , C07C311/37
摘要: The invention relates to a process for the production of tamsulosin hydrochloride crystals where the crystal size distribution is controlled by controlling the temperature where hydrochloric acid is added to the reaction mixture.
摘要翻译: 本发明涉及一种生产盐酸坦索罗辛晶体的方法,其中通过控制向反应混合物中加入盐酸的温度来控制晶体尺寸分布。
-
公开(公告)号:WO2006134212A2
公开(公告)日:2006-12-21
申请号:PCT/FI2006/000201
申请日:2006-06-14
申请人: FERMION OY , GRUMANN, Arne , HUHTA, Soini , LUUKKONEN, Eila , KOIRANEN, Tuomas
发明人: GRUMANN, Arne , HUHTA, Soini , LUUKKONEN, Eila , KOIRANEN, Tuomas
IPC分类号: C07C303/40 , C07C311/37
CPC分类号: C07C303/40 , C07C311/37
摘要: The invention relates to a process for the production of tamsulosin hydrochloride crystals where the crystal size distribution is controlled by controlling the temperature where hydrochloric acid is added to the reaction mixture.
摘要翻译: 本发明涉及一种生产盐酸坦索罗辛晶体的方法,其中通过控制向反应混合物中加入盐酸的温度来控制晶体尺寸分布。
-
公开(公告)号:WO2005028459A1
公开(公告)日:2005-03-31
申请号:PCT/FI2004/000561
申请日:2004-09-23
申请人: FERMION OY , HILDEN, Leif , GRUMANN, Arne , HUHTA, Soini , RUMMAKKO, Petteri
发明人: HILDEN, Leif , GRUMANN, Arne , HUHTA, Soini , RUMMAKKO, Petteri
IPC分类号: C07D295/20
CPC分类号: C07D295/215 , C07D281/16 , C07D417/14
摘要: The present invention discloses a process for the preparation of quetiapine, which comprises the ring closure and deprotection of a compound of the formula (I), as well as novel intermediates in the process.
摘要翻译: 本发明公开了一种制备喹硫平的方法,其包括式(I)化合物的闭环和脱保护,以及该方法中的新型中间体。
-
公开(公告)号:WO2005028458A1
公开(公告)日:2005-03-31
申请号:PCT/FI2004/000560
申请日:2004-09-23
申请人: FERMION OY , RUMMAKKO, Petteri , HUHTA, Soini , GRUMANN, Arne
发明人: RUMMAKKO, Petteri , HUHTA, Soini , GRUMANN, Arne
IPC分类号: C07D281/16
CPC分类号: C07D295/192 , C07D281/16
摘要: The present invention discloses a process for the preparation of quetiapine, which comprises the ring closure of a compound of the formula shown below, as well as novel intermediates in the process.
摘要翻译: 本发明公开了一种制备喹硫平的方法,该方法包括以下结构式的化合物的闭环,以及该方法中的新型中间体。
-
-
-
-
-
-